Raffles Medical Group Ltd

RAFLF · OTC
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Market Cap$1,769,838$1,495,723$1,701,499$1,553,448
- Cash$334,183$334,183$343,671$343,671
+ Debt$83,834$88,525$88,168$92,373
Enterprise Value$1,519,489$1,250,065$1,445,996$1,302,150
Revenue$189,224$189,224$193,361$193,361
% Growth0%-2.1%0%
Gross Profit$86,942$86,942$87,372$87,372
% Margin45.9%45.9%45.2%45.2%
EBITDA$31,186$31,186$27,541$27,541
% Margin16.5%16.5%14.2%14.2%
Net Income$16,054$16,054$15,800$15,800
% Margin8.5%8.5%8.2%8.2%
EPS Diluted0.0090.0090.0090.009
% Growth0%1.2%0%
Operating Cash Flow$28,300$28,300$25,844$25,844
Capital Expenditures-$1,423-$1,423-$3,796-$3,796
Free Cash Flow$26,878$26,878$22,048$22,048
Raffles Medical Group Ltd (RAFLF) Financial Statements & Key Stats | AlphaPilot